ARTICLE | Clinical News
Eniluracil regulatory update
January 2, 2006 8:00 AM UTC
FDA granted Orphan Drug designation to eniluracil in combination with fluoropyrimidines to treat hepatocellular cancer. Eniluracil is a dihydropyrimidine dehydrogenase inhibitor. ...